Ascend Laboratories, LLC 2023-02-01 Health serious FDA
Health · FDA · Recall #FDA-D-0169-2023
Metoprolol Succinate Extended-Release Tablets, USP 25 mg, Rx Only, 100 Tablets per… Recall
Issued February 1, 2023 · Ascend Laboratories, LLC
In February 2023, Ascend Laboratories, LLC recalled the Metoprolol Succinate Extended-Release Tablets, USP 25 mg, Rx Only, 100 Tablets per…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Dissolution Specification
What you should do
- 1 Stop using Metoprolol Succinate Extended-Release Tablets, USP 25 mg, Rx Only, 100 Tablets per… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Ascend Laboratories, LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Ascend Laboratories, LLC
- Category
- Health
- Recall date
- February 1, 2023
- Units affected
- Not reported
- Sold at
- Nationwide and Puerto Rico
- Recall number
- FDA-D-0169-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Ascend Laboratories, LLC has 12 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.